Hypersensitivity reactions associated with endovascular devices

Contact Dermatitis

Volumn 59, Issue 1, 2008, Pages 7-22

  Honari, Golara ^a   Ellis, Stephen G ^a,b   Wilkoff, Bruce L ^a,b   Aronica, Mark A ^a,b   Svensson, Lars G ^a,c   Taylor, James S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Center for Aortic Surgery   (United States)

Author keywords

Allergic contact dermatitis; Amplatzer; Cardioverter defibrillators; Endovascular devices; Hypersensitivity; Implantable; Metal allergy; Pacemaker; Patch test; Patent foramen ovale occluder; Stent restenosis

Indexed keywords

BIOMATERIAL; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ARTIFICIAL HEART PACEMAKER; BLOOD VESSEL PROSTHESIS; CORONARY STENT; DEFIBRILLATOR; DRUG ELUTING STENT; HUMAN; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; IMMUNOTOXICITY; PATCH TEST; REVIEW; SKIN ALLERGY;

ALLERGENS; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; DEFIBRILLATORS, IMPLANTABLE; DERMATITIS, ALLERGIC CONTACT; FORAMEN OVALE, PATENT; HEART DISEASES; HUMANS; HYPERSENSITIVITY; METALS; PACEMAKER, ARTIFICIAL; PATCH TESTS; PROSTHESES AND IMPLANTS; STENTS;

EID: 47249106421     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2008.01351.x     Document Type: Review

References (111)

1. Ratner B D, Hoffman A S, Schoen F J, Lemons J E. Biomaterials Science: An Introduction to Materials in Medicine, San Diego, Elsevier Academic Press, 2004.
2. U.S. Department Of Health And Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Molecular Biology Branch, Division of Life Sciences, Office of Science and Technology. Guidance for Industry and FDA Reviewers - Immunotoxicity Testing Guidance, Rockville, FDA, 1999 available from http://www.fda.gov/cdrh/ost/ostggp/immunotox.html) accessed on 16 June 2005.
3. Rajan T V. The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation. Trends Immunol 2003 : 24 : 376 379.
4. Roitt I, Brostoff J, Male D. Immunology. London, Mosby, 2001.
5. Mitchell J C. Type I without type III and type IV hypersensitivity reaction to nickel. Contact Dermatitis 1981 : 7 : 270.
6. van Kampen V, Merget R, Bruning T. Immediate type allergies due to metal - nickel. Pneumologie 2003 : 57 : 667 670.
7. Wooley P H, Fitzgerald R H Jr., Song Z et al. Proteins bound to polyethylene components in patients who have aseptic loosening after total joint arthroplasty. A preliminary report. J Bone Joint Surg Am 1999 : 81 : 616 623.
8. Virmani R, Guagliumi G, Farb A et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004 : 109 : 701 705.
9. Nebeker J R, Virmani R, Bennett C L et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006 : 47 : 175 181.
10. Bar-Meir E, Eherenfeld M, Shoenfeld Y. Silicone gel breast implants and connective tissue disease - a comprehensive review. Autoimmunity 2003 : 36 : 193 197.
11. Lipworth L, Tarone R E, McLaughlin J K. Silicone breast implants and connective tissue disease: an updated review of the epidemiologic evidence. Ann Plast Surg 2004 : 52 : 598 601.
12. Sigler M, Paul T, Grabitz R G. Biocompatibility screening in cardiovascular implants. Z Kardiol 2005 : 94 : 383 391.
13. King S B III., Meier B. Interventional treatment of coronary heart disease and peripheral vascular disease. Circulation 2000 : 102 : IV81 IV86.
14. Haudenschild C C. Pathobiology of restenosis after angioplasty. Am J Med 1993 : 94 : 40S 44S.
15. Babapulle M N, Joseph L, Belisle P, Brophy J M, Eisenberg M J. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004 : 364 : 583 591.
16. Holmes D R Jr., Savage M, LaBlanche J M et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2002 : 106 : 1243 1250.
17. Mathews R J. Cardiology; stent. 2002 available from http://www. rjmatthewsmd.com/) accessed on 23 May 2005.
18. Wataha I C, Sun Z L, Hanks C T, Fang D N. Effect of Ni ions on expression of intercellular adhesion molecule 1 by endothelial cells. J Biomed Mater Res 1997 : 36 : 145 151.
19. Wataha J C, O'Dell N L, Singh B B, Ghazi M, Whitford G M, Lockwood P E. Relating nickel-induced tissue inflammation to nickel release in vivo. J Biomed Mater Res 2001 : 58 : 537 544.
20. Messer R L, Wataha J C, Lewis J B, Lockwood P E, Caughman G B, Tseng W Y. Effect of vascular stent alloys on expression of cellular adhesion molecules by endothelial cells. J Long Term Eff Med Implants 2005 : 15 : 39 47.
21. Goebeler M, Roth J, Meinardus-Hager G, Sorg C. The contact allergens nickel chloride and cobalt chloride directly induce expression of endothelial adhesion molecules. Behring Inst Mitt 1993 : 92 : 191 201.
22. Goebeler M, Meinardus-Hager G, Roth J, Goerdt S, Sorg C. Nickel chloride and cobalt chloride, two common contact sensitizers, directly induce expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial leukocyte adhesion molecule (ELAM-1) by endothelial cells. J Invest Dermatol 1993 : 100 : 759 765.
23. Medtronic Vascular. Advantages of Cobalt Alloy for Coronary Stents, Minneapolis, Medtronic, 2003 available from http://www.medtronic.com/newsroom/ content/1110132739468.pdf) accessed on 20 February 2006.
24. Pratt M D, Belsito D V, DeLeo V A et al. North American Contact Dermatitis Group patch-test results, 2001-2002 study period. Dermatitis 2004 : 15 : 176 183.
25. Nielsen N H, Linneberg A, Menne T et al. Incidence of allergic contact sensitization in Danish adults between 1990 and 1998; the Copenhagen Allergy Study, Denmark. Br J Dermatol 2002 : 147 : 487 492.
26. Nielsen N H, Linneberg A, Menne T et al. Allergic contact sensitization in an adult Danish population: two cross-sectional surveys eight years apart (the Copenhagen Allergy Study). Acta Derm Venereol 2001 : 81 : 31 34.
27. Mosseri M, Tamari I, Plich M et al. Short- and long-term outcomes of the titanium-NO stent registry. Cardiovasc Revasc Med 2005 : 6 : 2 6.
28. Svedman C, Ekqvist S, Moller H, Bjork J, Gruvberger B et al. Unexpected sensitization routes and general frequency of contact allergies in an elderly stented swedish population. Contact Dermatitis 2007 : 56 : 338 343.
29. Van der Giessen W J, Lincoff A M, Schwartz R S et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996 : 94 : 1690 1697.
30. Cordis Corporation. CYPHER™ Sirolimus-Eluting Coronary Stent on RAPTORTM Over-the-Wire Delivery System, Miami Lakes, Cordis Corporation, 2003 available from http://www.fda.gov/cdrh/pdf3/P020026c.pdf) accessed on 12 February 2006.
31. Boston Scientific Corporation. Taxus - Paclitaxel-Eluting Coronary Stent System. Natick, Boston Scientific Corporation, 2003 available from http://www.fda.gov/ohrms/dockets/ac/03/briefing/4005b1_03_Labeling.pdf) accessed on 12 February 2006.
32. Boston Scientific Corporation. Directions for use. Natick, Boston Scientific Corporation, 2004 available from http://www.taxus-stent.com/usa/dfu. html?ClickType=rn-dfu) accessed on 12 February 2006.
33. Medtronic. Medtronic's Sterilization Process. CRM Technical Service Standard Letter Authors correspondence with Medtronics.
34. Purello D'Ambrosio F, Savica V, Gangemi S et al. Ethylene oxide allergy in dialysis patients. Nephrol Dial Transplant 1997 : 12 : 1461 1463.
35. Caroli U M, Berner D, Volz T, Rocken M, Biedermann T. Delayed-type hypersensitivity dermatitis to ethylene oxide. Contact Dermatitis 2005 : 53 : 303 304.
36. Dagregorio G, Guillet G. Allergic suture material contact dermatitis induced by ethylene oxide. Allergy 2004 : 59 : 1239.
37. Pearson F, Bruszer G, Lee W et al. Ethylene oxide sensitivity in hemodialysis patients. Artif Organs 1987 : 11 : 100 103.
38. Taylor J S. Dermatologic hazards from ethylene oxide. Cutis 1977 : 19 : 189 192.
39. Dolovich J, Bell B. Allergy to a product(s) of ethylene oxide gas: demonstration of IgE and IgG antibodies and hapten specificity. J Allergy Clin Immunol 1978 : 62 : 30 32.
40. Koster R, Vieluf D, Kiehn M et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000 : 356 : 1895 1897.
41. Hillen U, Haude M, Erbel R, Goos M. Evaluation of metal allergies in patients with coronary stents. Contact Dermatitis 2002 : 47 : 353 356.
42. Svedman C, Tillman C, Gustavsson C G, Moller H, Frennby B, Bruze M. Contact allergy to gold in patients with gold-plated intracoronary stents. Contact Dermatitis 2005 : 52 : 192 196.
43. Ekqvist S, Svedman C, Lundh T, Moller H, Bjork J, Bruze M. Gold concentration in blood in patients treated with intracoronary stents. Contact Dermatitis 2006 : 55 : 9 (Abstract).
44. Norgaz T, Hobikoglu G, Serdar Z A et al. Is there a link between nickel allergy and coronary stent restenosis? Tohoku J Exp Med 2005 : 206 : 243 246.
45. Iijima R, Ikari Y, Amiya E et al. The impact of metallic allergy on stent implantation: metal allergy and recurrence of in-stent restenosis. Int J Cardiol 2005 : 104 : 319 325.
46. Keane F M, Morris S D, Smith H R, Rycroft R J. Allergy in coronary in-stent restenosis. Lancet 2001 : 357 : 1205 1206 author's reply 1206-1207.
47. Honari G, Taylor J S, Ellis S. Contact allergy to gold in patients with gold-plated intracoronary stents. Contact Dermatitis 2005 : 53 : 359.
48. Alonge L, Kroen M. Information for Physicians on Sub-Acute Thromboses (SAT) and Hypersensitivity Reactions with Use of the Cordis CYPHER™ Coronary Stent, Rockville, FDA, 2003 available from http://www.fda.gov/cdrh/ safety/cypher.html) accessed on 12 February 2006.
49. Alonge L, Kroen M. Updated Information for Physicians on Sub-Acute Thromboses (SAT) and Hypersensitivity Reactions with Use of the Cordis CYPHER™ Sirolimus-Eluting Coronary Stent, Rockville, FDA, 2003 available from http://www.fda.gov/cdrh/safety/cypher2.html) accessed on 12 February 2006.
50. Alonge L. Final Update of Information for Physicians on Sub-Acute Thromboses (SAT) and Hypersensitivity Reactions with Use of the Cordis CYPHER™ Sirolimus-eluting Coronary Stent, Rockville, FDA, 2004 available from http://www.fda.gov/cdrh/safety/cypher3.html) accessed on 20 January 2006.
51. Bennett C L, Nebeker J R, Lyons E A et al. The research on adverse drug events and reports (RADAR) project. JAMA 2005 : 293 : 2131 2140.
52. Kritharides L, Yiannikas J, Brieger D, Allman K. Images in cardiovascular medicine. Coronary uptake of gallium-67 citrate after implantation of sirolimus-eluting stent. Circulation 2004 : 109 : 2156.
53. Mills N L, King T D. Nonoperative closure of left-to-right shunts. J Thorac Cardiovasc Surg 1976 : 72 : 371 378.
54. Sievert H, Babic U U, Hausdorf G et al. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 1998 : 82 : 1405 1413.
55. FDA Document - Amplatzer. Summary of Safety and Probable Benefit. 2000 available from http://www.fda.gov/cdrh/pdf/h000007b.pdf) accessed on 12 February 2006.
56. FDA Document. CardioSEALÒ Septal Occlusion System with Qwik LoadÔ Summary of Safety and Effectiveness Data. 2001 available from http://www.fda.gov/cdrh/pdf/P000049b.pdf) accessed on 12 February 2006.
57. Ries M W, Kampmann C, Rupprecht H J, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the Amplatzer occluder. Am Heart J 2003 : 145 : 737 741.
58. Fukahara K, Minami K, Reiss N, Fassbender D, Koerfer R. Systemic allergic reaction to the percutaneous patent foramen ovale occluder. J Thorac Cardiovasc Surg 2003 : 125 : 213 214.
59. Dasika U K, Kanter K R, Vincent R. Nickel allergy to the percutaneous patent foramen ovale occluder and subsequent systemic nickel allergy. J Thorac Cardiovasc Surg 2003 : 126 : 2112.
60. Singh H R, Turner D R, Forbes T J. Nickel allergy and the amplatzer septal occluder. J Invasive Cardiol 2004 : 16 : 681 682.
61. Medtronic. History of Pacemakers: Technology Development Through the Decades. Minneapolis, Medtronic available from http://www.medtronic.com/brady/ patient/pacemaker_history.html) accessed on 12 April 2006.
62. Mirowski M. The automatic implantable cardioverter-defibrillator: an overview. J Am Coll Cardiol 1985 : 6 : 461 466.
63. Medcompare. Implantable Cardiac EP Devices available from http://www.medcompare.com/jump/529/Implantable-Cardiac-EP-Devices.html) accessed on 12 April 2006.
64. DiFilippo F P, Brunken R C. Do implanted pacemaker leads and ICD leads cause metal-related artifact in cardiac PET/CT? J Nucl Med 2005 : 46 : 436 443.
65. St. Jude Medical. Pacemakers, St. Paul, St. Jude Medical available from http://www.sjm.com/resources/learnmoreabout.aspx?section=CardiacPacemakerSystem) accessed on 12 April 2006.
66. Dionisio P. Advances in the technology of pacing. Rev Port Cardiol 1999 : 18 : 289 298.
67. Weiss R. Pacemaker dermatitis. Contact Dermatitis 1989 : 21 : 343 344.
68. Buchet S, Blanc D, Humbert P et al. Pacemaker dermatitis. Contact Dermatitis 1992 : 26 : 46 47.
69. Iguchi N, Kasanuki H, Matsuda N, Shoda M, Ohnishi S, Hosoda S. Contact sensitivity to polychloroparaxylene-coated cardiac pacemaker. Pacing Clin Electrophysiol 1997 : 20 : 372 373.
70. Hayes D L, Loesl K. Pacemaker component allergy: case report and review of the literature. J Interv Card Electrophysiol 2002 : 6 : 277 278.
71. Skoet R, Tollund C, Bloch-Thomsen P E. Epoxy contact dermatitis due to pacemaker compounds. Cardiology 2003 : 99 : 112.
72. Andersen K E. Cutaneous reaction to an epoxy-coated pacemaker. Arch Dermatol 1979 : 115 : 97 98.
73. Landwehr A J, van Ketel W G. Pompholyx after implantation of a nickel-containing pacemaker in a nickel-allergic patient. Contact Dermatitis 1983 : 9 : 147.
74. Brun R, Hunziker N. Pacemaker dermatitis. Contact Dermatitis 1980 : 6 : 212 213.
75. Abdallah H I, Balsara R K, O'Riordan A C. Pacemaker contact sensitivity: clinical recognition and management. Ann Thorac Surg 1994 : 57 : 1017 1018.
76. Ishii K, Kodani E, Miyamoto S et al. Pacemaker contact dermatitis: the effective use of a polytetrafluoroethylene sheet. Pacing Clin Electrophysiol 2006 : 29 : 1299 1302.
77. Hiranaka T, Nomura F, Kurozumi K. Pacemaker contact dermatitis treated by wrapping with a polytetrafluoroethylene (PTFE) sheet. Pacing Clin Electrophysiol 1992 : 8 : 335 338.
78. Kono K, Hara K, Higashi T et al. Pacemaker contact dermatitis treated with polytetrafluoroethylene sheet. J Arrhythmia 2000 : 16 : 403 407.
79. Tujita J, Nakamura K, Yasumoto S, Ueno Y. Pacemaker dermatitis: report of two cases. Nishinihon J Dermatol 1996 : 58 : 200 202.
80. Dery J P, Gilbert M, O'Hara G et al. Pacemaker contact sensitivity: case report and review of the literature. Pacing Clin Electrophysiol 2002 : 25 : 863 865.
81. Freeman S. Allergic contact dermatitis to titanium in a pacemaker. Contact Dermatitis 2006 : 55 : 41.
82. Ferringer T, Mowad C. Telangiectatic erythematous cutaneous reaction to an implantable cardioverter defibrillator. Am J Contact Dermat 2003 : 14 : 37 40.
83. Maushagen E, Reichle B, Simon H. Circumscribed erythema after cardiac pacemaker implantation. Z Kardiol 1994 : 83 : 340 342.
84. Wilkerson M G, Jordan W P Jr. Pressure dermatitis from an implanted pacemaker. Dermatol Clin 1990 : 8 : 189 192.
85. Chua J D, Wilkoff B L, Lee I, Juratli N, Longworth D L, Gordon S M. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000 : 133 : 604 608.
86. Dy Chua J, Abdul-Karim A, Mawhorter S, Procop G W, Tchou P et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol 2005 : 28 : 1276 1281.
87. Lyell A, Bain W H. Letter: nickel allergy and valve replacement. Lancet 1974 : 1 : 408 409.
88. Lyell A, Bain W H, Thomson R M. Repeated failure of nickel-containing prosthetic heart valves in a patient allergic to nickel. Lancet 1978 : 2 : 657 659.
89. Gimenez-Arnau A, Riambau V, Serra-Baldrich E, Camarasa J G. Metal-induced generalized pruriginous dermatitis and endovascular surgery. Contact Dermatitis 2000 : 43 : 35 40.
90. Hallab N, Merritt K, Jacobs J J. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am 2001 : 83-A : 428 436.
91. Carlsson A, Moller H. Implantation of orthopaedic devices in patients with metal allergy. Acta Derm Venereol 1989 : 69 : 62 66.
92. Fleming C J, Burden A D, Forsyth A. Accuracy of questions related to allergic contact dermatitis. Am J Contact Dermat 2000 : 11 : 218 221.
93. Kubba R, Taylor J S, Marks K E. Cutaneous complications of orthopedic implants. A two-year prospective study. Arch Dermatol 1981 : 117 : 554 560.
94. Poncin P, Millet C, Chevy J, Proft J L. Comparing and Optimizing Co-Cr Tubing for Stent Applications. Proceedings from the Materials & Processes for Medical Devices Conference 25-27 Aug 2004, St. Paul, MN, USA. The Materials Information Society available from www.minitubes.com/images/brochure/asm04.pdf) accessed on 20 February 2005.
95. Mark N, Frake P, Kazanjian M, Yu L. Organ Replacement Web Page Final Project 2004, Providence, Brown University, 2004 available from http://biomed.brown.edu/Courses/BI108/BI108_2004_Groups/Group05/ Drug%20Eluting%20Stents/products_and_clinical_trials.htm) BI108 2004. accessed on 20 December 2006.
96. ® Sirolimus-Eluting Coronary Stent, Miami Lakes, Cordis Corporation, 2005 available from http://www.jnj.com/ innovations/new_features/cypher_stent.htm;jsessionid=C4IHQ41Z2IRG4CQPCAOWU3YKB) accessed on 15 May 2007.
97. European Medicines Agency. Pre-authorisation evaluation of medicines for human. 2006 available from http://www.emea.europa.eu/pdfs/human/ewp/5647706en. pdf accessed on 30 July 2007.
98. ® Express2™ Paclitaxel-Eluting Coronary Stent System, Natick, Boston Scientific Corporation, 2007 available from http://www.bostonscientific.com/med_specialty/deviceDetail. jsp?task=tskBasicDevice.jsp§ionId=4&relId=2,74,75,76&deviceId= 11013) accessed on 15 May 2007.
99. Riley K. FDA Approves Drug-Eluting Stent for Clogged Heart Arteries. 2008 available from : http://www.fda.gov/bbs/topics/NEWS/2008/NEW01787.html) accessed on 15 May 2007.
100. Beijk M A, Piek J J. XIENCE V everolimus-eluting coronary stent system: A novel second generation drug-eluting stent. Expert Rev Med Devices 2007 : 4 : 11 21.
101. Lai D W, Saver J L, Araujo J A, Reidl M, Tobis J. Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report. Catheter Cardiovasc Interv 2005 : 66 : 424 426.
102. Peters M S, Schroeter A L, van Hale H M, Broadbent J C. Pacemaker contact sensitivity. Contact Dermatitis 1984 : 11 : 214 218.
103. Viraben R, Boulinguez S, Alba C. Granulomatous dermatitis after implantation of a titanium-containing pacemaker. Contact Dermatitis 1995 : 33 : 437.
104. Yamauchi R, Morita A, Tsuji T. Pacemaker dermatitis from titanium. Contact Dermatitis 2000 : 42 : 52 53.
105. Laugier P, Hunziger N, Orusco M, Brun B, Reiffers J, Posternak F. Dermite de contact par pacemaker. Dermatologica 1975 : 150 : 219 226.
106. Tilsley D A, Rotstein H. Sensitivity caused by internal exposure to nickel, chrome and cobalt. Contact Dermatitis 1980 : 6 : 175 178.
107. Moini C, d'Alteroche A, Cosnay P, Vaillant L, Babuty D et al. Contact dermatitis following cardiac pacemaker implantation. Arch Mal Coeur Vaiss 1996 : 89 : 253 256.
108. Romaguera C, Grimalt F. Pacemaker dermatitis. Contact Dermatitis 1981 : 7 : 333.
109. Raque C, Goldschmidt H. Dermatitis associated with an implanted cardiac pacemaker. Arch Dermatol 1970 : 102 : 646 649.
110. Verbov J. Pacemaker contact sensitivity. Contact Dermatitis 1985 : 12 : 173.
111. Gimenez C J. Dermites au pacemaker. Acta Dermatol 1985 : 8 : 117 119.